1. Home
  2. AI vs BCRX Comparison

AI vs BCRX Comparison

Compare AI & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C3.ai Inc.

AI

C3.ai Inc.

SELL

Current Price

$11.07

Market Cap

2.0B

Sector

Technology

ML Signal

SELL

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

SELL

Current Price

$7.51

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AI
BCRX
Founded
2009
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
AI
BCRX
Price
$11.07
$7.51
Analyst Decision
Sell
Buy
Analyst Count
13
11
Target Price
$8.90
★ $20.45
AVG Volume (30 Days)
3.8M
★ 5.4M
Earning Date
12-02-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 381.40
EPS
★ N/A
N/A
Revenue
★ $250,268,000.00
$25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.76
$3.71
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.68
$6.23
52 Week High
$16.40
$11.22

Technical Indicators

Market Signals
Indicator
AI
BCRX
Relative Strength Index (RSI) 42.81 40.63
Support Level $11.07 N/A
Resistance Level $11.14 $8.83
Average True Range (ATR) 0.54 0.37
MACD -0.08 -0.03
Stochastic Oscillator 0.33 13.55

Price Performance

Historical Comparison
AI
BCRX

About AI C3.ai Inc.

C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions, namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications; C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications; and C3 Generative AI, which combines the utility of large language models. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: